Neurosurgeon and scientist Dr. Jandial joined us to discuss a major breakthrough in pain medication recently approved by the ...
An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the ...
The FDA approved the investigational new drug application for a phase 1 trial of ADCE-T02 in advanced solid tumors.
The U.S. Centers for Disease Control says VRBPAC “makes the final decision about which vaccine viruses to include in the ...
ITF, IntraBio and Orchard are among the companies that have won FDA nods in the past year for Duchenne muscular dystrophy, ...
Outsourcing Facilities Association and North American Custom Laboratories allege the FDA removed semaglutide from its ...
Vantage Specialty Chemicals, Inc., (Vantage) today announced that its VYCERIN™ API Glycerin, USP is listed on the Drug Master File (DMF-040171) with the U.S. Food and Drug Administration (FDA).
FDA reform needs to be underpinned by strategy, not ‘indiscriminate’ cuts The Trump administration could save the lives of ...
The Trump administration has canceled an upcoming meeting of the Food and Drug Administration’s vaccine advisory committee, a ...
This is the second cancellation to vaccine-related advisory panels since RFK Jr. took the helm at the Department of Health and Human Services.
The FDA canceled a critical annual flu vaccine planning meeting without explanation days after Robert F. Kennedy Jr. took ...
The March meeting was set to vote on which flu strains would offer the most protection for next season’s flu shot.